Skip to content

Agios Pharmaceuticals AGIO Compensation and benefits

Compensation and benefits at other companies

Pfizer logo
PfizerPFE
Incyte logo
IncyteINCY
BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN
Precigen logo
PrecigenPGEN
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
BridgeBio Pharma logo
BridgeBio PharmaBBIO

Other financials

Income statement

See full
Revenue$20.7M+138%
Gross profit$19.4M+154%
Operating income-$110.0M-3.2%
Net income-$99.1M-11.0%
EPS (diluted)-$1.69-9.0%

Balance sheet

See full
Cash & equivalents$113.6M+43.9%
Total debt$35.7M-32.5%
Total equity$1.1B-24.4%
Total assets$1.2B-23.8%

Cash flow

See full
Operating cash flow-$118.9M-6.7%
CapEx$769.0K+0.4%
Free cash flow-$119.7M-6.6%

Valuation

See full
Market cap$2.16B+18.1%

Profitability

See full
Gross margin90%+2.5pp
Operating margin-720%-204pp
Net margin-639.8%
FCF margin-582.5%-185pp

Returns & leverage

See full
Return on equity-32.8%
Debt / equity0.0×
Current ratio14.2×-4.3×

Where this comes from

Reported directly by Agios Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The official record: Agios Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Agios Pharmaceuticals's compensation and benefits.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Agios Pharmaceuticals's compensation and benefits?
Agios Pharmaceuticals (AGIO) reported compensation and benefits of $11.69M in Q1 2026.
How has Agios Pharmaceuticals's compensation and benefits changed year-over-year?
Agios Pharmaceuticals's compensation and benefits increased by 49.8% year-over-year, from $7.8M to $11.69M.
What is the long-term trend for Agios Pharmaceuticals's compensation and benefits?
Over 5 years (2020 to 2025), Agios Pharmaceuticals's compensation and benefits has grown at a 6.0% compound annual growth rate (CAGR), from $20.35M to $27.26M.